Trip.com Group Limited (TCOM) PT Raised to $33 at Jefferies; 'Long-Term Thesis Is Intact'

Go back to Trip.com Group Limited (TCOM) PT Raised to $33 at Jefferies; 'Long-Term Thesis Is Intact'

Mizuho Securities Reiterates Buy Rating on Trip.com Group Limited (TCOM) Following Q2 EPS

September 22, 2022 6:43 AM EDT

Mizuho Securities analyst James Lee reiterated a Buy rating and $30.00 price target on Trip.com Group Limited (NASDAQ: TCOM) following results which showed strong pent-up demand for travel.

The analyst commented, "Results came in above expectations despite lockdowns in 2Q22.... More

After-Hours Movers: Salesforce Gains on Strong LT Guidance, KB Home Falls Post EPS

September 21, 2022 6:06 PM EDT

After-Hours Stock Movers:

DBV Technologies (Nasdaq: DBVT) INDICATED 20%+ LOWER; announced that it received feedback from the U.S. Food and Drug Administration (FDA) in the form of a partial clinical hold on its VITESSE (Viaskin Peanut Immunotherapy Trial to Evaluate Safety, Simplicity and Efficacy) Phase 3... More

Trip.com Group (TCOM) Misses Q2 EPS, Revenue Beats

September 21, 2022 6:01 PM EDT

Trip.com Group (NASDAQ: TCOM) reported Q2 EPS of (RMB0.31), RMB0.46 worse than the analyst estimate of RMB0.15. Revenue for the quarter came in at RMB4 billion versus the consensus estimate of RMB3.58 billion.

For earnings history and earnings-related data on Trip.com Group (TCOM) click here.

... More